Self-boosting stimulus activation of a polyprodrug with cascade amplification for enhanced antitumor efficacy

Area of Science:

• Biomedical Engineering
• Polymer Chemistry
• Oncology

Background:

• Polyprodrugs offer targeted cancer therapy by linking drugs to polymers via responsive linkers.
• Limited endogenous triggering factors in tumors restrict drug activation, hindering efficacy.
• Developing stimuli-responsive systems for controlled drug release is crucial for cancer treatment.

Purpose of the Study:

• To rationally design a reactive oxygen species (ROS)-sensitive polyprodrug with cascade amplification for enhanced cancer therapy.
• To create a delivery system that amplifies both triggering signals and drug activation within tumor tissues.
• To overcome the limitations of insufficient endogenous triggering factors for polyprodrug activation.

Main Methods:

• Incorporation of a ROS signal amplifier (TA_CA) and a drug activation amplifier (SIP_DOX) into a polyprodrug delivery system.
• Utilizing endogenous ROS as the initial trigger to amplify intracellular ROS signals.
• Designing a domino-like degradation cascade for self-accelerated drug release upon enhanced ROS stimulation.

Main Results:

• The developed polyprodrug (TS_CA/DOX) demonstrated a cascade amplification of triggering agents and drug activation.
• Endogenous ROS initiated a process that amplified ROS signals within the tumor microenvironment.
• The amplified ROS triggered spontaneous, domino-like fracturing of the polyprodrug, leading to self-accelerated drug activation.

Conclusions:

• The rationally designed ROS-sensitive polyprodrug exhibits cascade amplification for enhanced drug activation in tumor tissues.
• This novel polyprodrug system holds significant promise for effective cancer treatment due to its self-accelerated drug release mechanism.
• The strategy of amplifying both triggering signals and drug activation offers a potent approach for advanced cancer therapeutics.